Millennium Management’s Palisade Bio PALI Stock Holding History

Millennium Management’s Portfolio PALI Stock Details PALI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$3.68M	Buy	2,103,353 +1,808,867	+614%	+$3.29M	﹤0.01%	3277
2025 Q4	$692K	Buy	+294,486	New	+$566K	﹤0.01%	4739
2024 Q2	–	Sell	-1,213	Closed	-$7.26K	–	6359
2024 Q1	$7.26K	Buy	+1,213	New	+$8.46K	﹤0.01%	5969
2022 Q4	–	Sell	-91	Closed	-$7K	–	6912
2022 Q3	$7K	Buy	91 +66	+264%	+$14K	﹤0.01%	6739
2022 Q2	$8K	Buy	+25	New	+$12K	﹤0.01%	6725
2017 Q2	–	Hold	0	–	-$62K	–	3749
2017 Q1	–	Hold	0	–	–	–	3367
2016 Q2	–	Hold	0	–	-$183K	–	3460
2016 Q1	–	Hold	0	–	–	–	2979
2015 Q4	–	Sell	-1	Closed	-$1.35M	–	2830
2015 Q3	$816K	Hold	1	–	–	﹤0.01%	2400
2015 Q2	$1.47M	Buy	+1	New	+$2.18M	﹤0.01%	2076
2014 Q3	–	Hold	0	–	-$1.18M	–	3925
2014 Q2	–	Hold	0	–	–	–	2104
2014 Q1	–	Hold	0	–	–	–	3333

Other funds holding PALI

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

BGI

B Group Inc Dallas, Texas $135M AUM 80% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

OCA

Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return

Millennium Management's PALI Position: Q1 2026 in Review

Millennium Management increased its Palisade Bio (PALI) stake by 614% in Q1 2026, buying an estimated $3.29M and bringing the position to 2,103,353 shares worth $3.68M. The position accounts for ﹤0.01% of the portfolio, ranked #3277.

Millennium Management first reported a position in PALI in Q2 2015 and has held it in 7 quarters since. 96 funds tracked by Wall St. Rank hold PALI as of Q1 2026.

Millennium Management held 2,103,353 shares of Palisade Bio worth $3.68M as of Q1 2026.
Millennium Management bought 1,808,867 Palisade Bio shares in Q1 2026, an estimated $3.29M.
Palisade Bio made up ﹤0.01% of Millennium Management's portfolio in Q1 2026, its #3277 holding.
Millennium Management first reported a position in Palisade Bio in Q2 2015 and has held it in 7 quarters since.
96 funds tracked by Wall St. Rank held Palisade Bio as of Q1 2026.

Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.